Martin Sjöström Selected Research

Segmental Mastectomy (Lumpectomy)

10/2023	Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer.
1/2023	Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
1/2023	Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
1/2022	Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.
1/2021	Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial.
1/2020	Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy.
12/2019	Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer.
10/2019	Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial.
1/2018	Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
10/2017	Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Sjöström Research Topics

Disease

31	Neoplasms (Cancer) 10/2023 - 05/2014
18	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 11/2017
18	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2013
5	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2015
3	Disease Progression 11/2022 - 01/2016
2	Lymphatic Metastasis 12/2022 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 01/2021
1	Adenocarcinoma 12/2022
1	Carcinoma (Carcinomatosis) 12/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Carcinogenesis 01/2022
1	Melanoma (Melanoma, Malignant) 12/2020
1	Lobular Carcinoma 06/2019

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2015
9	Estrogen ReceptorsIBA 10/2023 - 04/2013
6	Phenobarbital (Luminal)FDA Link 10/2023 - 10/2017
6	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 06/2019
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
4	Tamoxifen FDA LinkGeneric 10/2023 - 04/2013
4	AndrogensIBA 01/2023 - 11/2021
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 11/2021
4	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 04/2013
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2022
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 10/2017
2	enzalutamideIBA 01/2023 - 01/2022
2	hydrogen sulfite (bisulfite)IBA 01/2023 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 12/2022 - 01/2021
2	enfortumab vedotinIBA 12/2022 - 01/2021
2	AntigensIBA 01/2021 - 12/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2019 - 05/2014
1	PlasticsIBA 10/2023
1	niraparibIBA 10/2023
1	Abiraterone AcetateIBA 10/2023
1	SteroidsIBA 07/2023
1	Hormones (Hormone)IBA 07/2023
1	abirateroneIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	ChromatinIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2022
1	sacituzumab govitecanIBA 12/2022
1	Cell-Free Nucleic AcidsIBA 11/2022
1	5-hydroxymethylcytosineIBA 11/2022
1	Dasatinib (BMS 354825)FDA Link 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Proto-Oncogene Proteins c-etsIBA 01/2022
1	PanobinostatIBA 01/2022
1	AutoantibodiesIBA 12/2020
1	EpitopesIBA 12/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Messenger RNA (mRNA)IBA 11/2017
1	Aldehyde DehydrogenaseIBA 12/2015
1	GlycopeptidesIBA 07/2015
1	ProteomeIBA 07/2015
1	Peptides (Polypeptides)IBA 07/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 04/2013

Therapy/Procedure

13	Therapeutics 10/2023 - 01/2015
11	Radiotherapy 01/2023 - 10/2017
10	Castration 10/2023 - 11/2017
10	Segmental Mastectomy (Lumpectomy) 10/2023 - 10/2017
6	Adjuvant Radiotherapy 10/2023 - 10/2017
2	Immunotherapy 12/2020 - 01/2019
1	Prostatectomy (Retropubic Prostatectomy) 07/2023
1	Aftercare (After-Treatment) 11/2021